Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

NCT06723691 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Acetaminophen
DRUG: Metformin
DRUG: Warfarin
DRUG: Atorvastatin
DRUG: Digoxin
DRUG: HRS9531

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.